{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:14:49Z","timestamp":1760908489593},"reference-count":25,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1984,12]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 The authors have conducted a Phase II trial to evaluate orally administered dibromodulcitol in the treatment of 40 evaluable patients with recurrent medulloblastoma, ependymoma, and malignant astrocytoma. Ten of 20 patients harboring medulloblastoma responded to therapy with a median time to tumor progression (MTP) of 40 weeks, and four of 20 patients had no sign of progression of disease 4 years after treatment was begun. The MTP for all 12 patients with ependymoma was 30 weeks. Nine of these 12 patients had stabilization of their disease with an MTP of 67 weeks; three of these 12 patients had no signs of progression for 1 to 3 years after treatment was begun. Of six patients harboring supratentorial gliomas, none responded to dibromodulcitol. Two patients, one with a primitive neuroectodermal tumor and the other with a metastatic carcinoma of the breast, had stabilization of disease for more than 4 and 2 years, respectively.<\/jats:p>","DOI":"10.3171\/jns.1984.61.6.1063","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T18:26:07Z","timestamp":1241807167000},"page":"1063-1068","source":"Crossref","is-referenced-by-count":28,"title":["Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma"],"prefix":"10.3171","volume":"61","author":[{"given":"Victor A.","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S. B.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip H.","family":"Gutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Vestnys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorcas","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Seager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3171\/jns.1983.59.1.0106","article-title":"Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.","volume":"59","author":"Afra","year":"1983"},{"key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3171\/jns.1981.55.5.0749","article-title":"High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.","volume":"55","author":"Allen","year":"1981"},{"key":"b3","series-title":"Cancer Chemother Rep","first-page":"61","article-title":"Phase I study of dibromodulcitol (NSC-104800).","volume":"55","author":"Andrews","year":"1971"},{"key":"b4","series-title":"Cancer Chemother Rep","first-page":"653","article-title":"Phase II study of dibromodulcitol (NSC-104800).","volume":"58","author":"Andrews","year":"1974"},{"key":"b5","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt1972134563","article-title":"The absorption and metabolism of dibromodulcitol in patients with advanced cancer.","volume":"13","author":"Belej","year":"1972"},{"key":"b6","series-title":"Cancer Treat Rep","article-title":"Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.","volume":"62","author":"Bellet","year":"1978"},{"key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/jns.1981.55.1.0043","article-title":"Radiation treatment for medulloblastoma. A 21-year review.","volume":"55","author":"Berry","year":"1981"},{"key":"b8","series-title":"Med Pediatr Oncol","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/mpo.2950040309","article-title":"Combination chemotherapy with MOPP in children with recurrent brain tumors.","volume":"4","author":"Cangir","year":"1978"},{"key":"b9","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/1097-0142(19810201)47:3<442::AID-CNCR2820470304>3.0.CO;2-1","article-title":"Clinical trials with the hexitol derivatives in the U.S.","volume":"47","author":"Chiuten","year":"1981"},{"key":"b10","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3171\/jns.1978.49.4.0589","article-title":"Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.","volume":"49","author":"Crafts","year":"1978"},{"key":"b11","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/1097-0142(197901)43:1<41::AID-CNCR2820430105>3.0.CO;2-U","article-title":"Combination chemotherapy in recurrent medulloblastoma.","volume":"43","author":"Duffner","year":"1979"},{"key":"b12","series-title":"Dibromodulcitol.","first-page":"174","article-title":"Ten-year international clinical experience with DBD in the treatment of malignant diseases","author":"Eckhardt","year":"1982"},{"key":"b13","series-title":"Cancer Treat Rep","first-page":"1179","article-title":"Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.","volume":"64","author":"Edwards","year":"1980"},{"key":"b14","series-title":"Eur J Cancer Clin Oncol","first-page":"337","article-title":"Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBD.","volume":"15","author":"Horv\u00e1th","year":"1979"},{"key":"b15","series-title":"J Am Stat Assoc","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958"},{"key":"b16","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3171\/jns.1974.40.3.0365","article-title":"Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.","volume":"40","author":"Kumar","year":"1974"},{"key":"b17","series-title":"Nitrosoureas: Current Status and New Developments.","first-page":"159","article-title":"Chemotherapy of recurrent brain tumors","author":"Levin","year":"1981"},{"key":"b18","series-title":"J Med Chem","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1021\/jm00180a022","article-title":"Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability.","volume":"23","author":"Levin","year":"1980"},{"key":"b19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3171\/jns.1977.47.3.0329","article-title":"Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors.","volume":"47","author":"Levin","year":"1977"},{"key":"b20","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/1097-0142(19830415)51:8<1364::AID-CNCR2820510808>3.0.CO;2-5","article-title":"Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma.","volume":"51","author":"Levin","year":"1983"},{"key":"b21","series-title":"Cancer Chemother Pharmacol","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00292883","article-title":"Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.","volume":"8","author":"Levin","year":"1982"},{"key":"b22","series-title":"Cancer Treat Rep","first-page":"2055","article-title":"Perturbed cell kinetics of 9L rat brain tumor cells following dianhydrogalactitol.","volume":"62","author":"Nomura","year":"1978"},{"key":"b23","series-title":"Cancer Chemother Rep","first-page":"377","article-title":"Clinical and pharmacologic experience with dibromodulcitol (NSC-104800), a new antitumor agent.","volume":"53","author":"Sellei","year":"1969"},{"key":"b24","series-title":"Cancer Chemother Rep","first-page":"989","article-title":"Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemic or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.","volume":"59","author":"Sitarz","year":"1975"},{"key":"b25","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archneur.1976.00500110007002","article-title":"Single-agent chemotherapy of brain tumors. A five-year review.","volume":"33","author":"Wilson","year":"1976"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/61\/6\/article-p1063.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/61\/6\/article-p1063.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/61\/6\/article-p1063.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T18:47:37Z","timestamp":1658688457000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/61\/6\/article-p1063.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":25,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/jns.1984.61.6.1063","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}